Tag Archives: UK

Regeneron v. Kymab – “Sufficiency” and Enablement in the U.K.

Guest post from Paul Cole. Regeneron Pharmaceuticals Inc v Kymab Ltd. [2020] UKSC 27 related to infringement of EP-B-1,360,287 and its divisional EP-B-2264123. The 287 parent related to a method of modifying an endogenous immunoglobulin variable region gene locus in … Continue reading

Posted in EP and UK Practice | Tagged | Leave a comment

TRANSMISSION OF INFORMATION IN EUROPE – PATENTABLE SUBJECT MATTER?

By Paul Cole, Lucas & Co., UK The UK counterpart of In re Ngai is Bayer’s (Meyer’s) Application [1984] R.P.C. 11. In that case a claim to a package containing a known drug together with instructions for a new use … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , , , | Leave a comment